Evidence map›Paper›PMID 38275655›Full record

ArticleAntioxidants (Basel, Switzerland)2024

High Tyrosol and Hydroxytyrosol Intake Reduces Arterial Inflammation and Atherosclerotic Lesion Microcalcification in Healthy Older Populations.

Nada Zoubdane, Redha-Alla Abdo, Michel Nguyen, M'hamed Bentourkia, Eric E Turcotte, Hicham Berrougui, Tamas Fulop, Abdelouahed Khalil

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Extra Virgin Olive Oil and Metabolic Diseases.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Review
  14. Potential Therapeutic Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nada ZoubdaneGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.
Redha-Alla AbdoGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.
Michel NguyenCardiology Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.ORCID 0000-0002-9845-5956
M'hamed BentourkiaDepartment of Nuclear Medicine and Radiobiology, University of Sherbrooke, Sherbrooke, QC J1K 2R1, Canada.
Eric E TurcotteSherbrooke Molecular Imaging Center (CIMS), 3001, 12th Ave N., Sherbrooke, QC J1H 5NY, Canada.
Hicham BerrouguiGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.ORCID 0000-0002-0546-6534
Tamas FulopGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.
Abdelouahed KhalilGeriatrics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC J1H 4N4, Canada.ORCID 0000-0003-0817-3160
Université de Sherbrooke · CA

Funding

CIHR PJT162366
6 · The paper itself

Abstract

Aging is an important risk factor for cardiovascular diseases and convincing data have shown that chronic low-grade inflammation, which develops with advanced age, contributes significantly to cardiovascular risk. The present study aimed to use

Indexed as

18F-FDG/18F-NaFagingatherosclerosishydroxytyrosolpositron emission tomographytyrosolvascular inflammation

Identifiers

PMID38275655
PMCPMC10812987
OpenAlexW4391105686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.